MedicNest.euLive Grid

bt_bb_section_bottom_section_coverage_image

Dates: 01/01/2019 31/05/2023 Topic: Tool AI/Big Data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5.3. – Using in-silico medicine for improving disease management and prediction Other Participating agents: TECHNIKON FORSCHUNGS- UND PLANUNGSGESELLSCHAFT MBH Keywords: paediatric; oncology; big data; cancer; machine learning; stadistics; tumour; clinical...

Dates: 01/03/2019 31/08/2024 Topic: Training Project type: Preclinic Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge Participating agents: UNIVERSITA CATTOLICA DEL SACRO CUORE Keywords: big data; AI; training; network; education; technology; policy; e-health Countries: Italy; Germany; Netherlands; Slovenia; UK; Belgium; Spain...

Dates: 01/09/2019 31/08/2026 Topic: Tool AI/Big Data Biomarkers identification Project type: Preclinic Clinic Guidelines Project target: Autoimmune disease Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD Keywords: systemic lupus erythematosus; rheumatoid arthritis; multiple sclerosis; asthma;...

Dates: 01/01/2020 30/09/2024 Topic: Procedures Project type: Medical Device Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.1. – Fostering new skills by means of excellent initial training of researchers Participating agents: UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO -AALTO KORKEAKOULUSAATIO SR -AO-FORSCHUNGSINSTITUT DAVOS -RIGAS TEHNISKA UNIVERSITATE -FACULTY OF TECHNOLOGY...

Dates: 01/09/2016 31/08/2023 Topic: Biomarkers identification Project type: Preclinic Project target: Endocrine disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: LUNDS UNIVERSITET -HELSINGIN YLIOPISTO -ACADEMISCH ZIEKENHUIS GRONINGEN -ITA-SUOMEN YLIOPISTO -UNIVERSITY OF DUNDEE -THE UNIVERSITY OF EXETER -Istituto di Ricerche Farmacologiche Mario...